This stock wont permanently break a dime until 4th quarter imo. March is here w no lympro rev or guidance. I doubt lympro rev exceeds 1 million in 2015. I dont forsee any partnerships in 2015, maybe a grant (not holding my breath) all other milestones dont move this stagnant stock. So there is my bold prediction jan 1st 2016 pps .10-.15
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links